Mode
Text Size
Log in / Sign up

Malnutrition and sarcopenia are associated with poorer treatment tolerance and higher toxicity in head and neck cancerMuscle Mass and Nutrition Impact Head and Neck Cancer Care

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that malnutrition and sarcopenia are associated with higher toxicity and poorer outcomes in head and neck cancer.

This narrative review examines the clinical impact of nutritional status, sarcopenia, and body-composition phenotypes, including CT-based analysis and morphofunctional assessment, in adult patients with head and neck cancer. The review synthesizes findings regarding how these physical markers influence treatment tolerance and clinical outcomes.

Key findings indicate that malnutrition, sarcopenia, and low skeletal muscle mass are associated with increased treatment-related toxicity and poorer treatment tolerance. Furthermore, these conditions are associated with prolonged hospitalization, higher postoperative complication rates, and reduced survival. These associations suggest that body-composition phenotypes are significant indicators of patient vulnerability.

Due to the narrative nature of the review, the evidence quality is not explicitly graded. The authors note that while these associations are observed, no direct causality is established. The review suggests that morphofunctional assessment may facilitate earlier identification of vulnerable patients to support individualized nutritional and rehabilitative interventions.

How this fits prior evidence

This narrative review extends the understanding of patient risk factors in head and neck cancer. It complements the finding that sarcopenia triples dysphagia odds across cancers by highlighting how sarcopenia and malnutrition also correlate with increased toxicity and reduced survival. It also aligns with the use of immunonutrition as a supportive measure by emphasizing the need for identifying vulnerable patients through morphofunctional assessment.

This review looked at how nutritional status and muscle mass affect adults with head and neck cancer. The researchers looked at how these factors influence how well patients tolerate treatment and their overall recovery. They specifically looked at conditions like sarcopenia, which is the loss of skeletal muscle mass.

The review found that patients with poor nutrition or low muscle mass often faced more serious challenges. These patients were more likely to experience higher rates of complications after surgery and had longer hospital stays. The findings also linked these physical conditions to a lower likelihood of surviving the disease.

Because this is a narrative review, the results show a link between muscle health and cancer outcomes rather than a direct cause. It suggests that identifying these issues early could help doctors provide better nutritional support and personalized care. Patients should talk to their medical team about how their nutrition and muscle health might affect their specific treatment plan.

What this means for you:
Poor nutrition and low muscle mass are linked to more complications and lower survival in head and neck cancer.

Common questions

How does muscle mass affect cancer treatment?

The review shows that patients with low skeletal muscle mass and sarcopenia may have poorer treatment tolerance. These patients are more likely to experience treatment-related toxicity and may face more challenges during their recovery process.

Can nutrition impact recovery after surgery?

Yes, the review indicates that malnutrition and poor body composition are linked to higher postoperative complication rates and longer stays in the hospital for patients with head and neck cancer.

What is the link between muscle loss and survival?

The findings show that patients with low skeletal muscle mass and poor nutritional status are associated with reduced survival rates. This highlights the importance of monitoring physical health during cancer treatment.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
Malnutrition, sarcopenia, and adverse body-composition phenotypes are highly prevalent in patients with head and neck cancer (HNC) and have been increasingly recognized as clinically relevant predictors of treatment tolerance, treatment-related toxicity, and oncologic outcomes. Morphofunctional assessment has emerged as a comprehensive approach for evaluating nutritional and functional status beyond conventional anthropometric measures. A narrative review was conducted using a structured literature search in PubMed/MEDLINE, Scopus, and Web of Science from database inception to June 2026. Studies evaluating the relationship between nutritional status, sarcopenia, body composition, treatment tolerance, treatment-related toxicity, functional outcomes, and prognosis in adult patients with HNC were considered. Clinical practice guidelines, systematic reviews, meta-analyses, and original studies published in English or Spanish were included. Current evidence demonstrates that malnutrition, sarcopenia, and low skeletal muscle mass are consistently associated with increased treatment-related toxicity, poorer treatment tolerance, prolonged hospitalization, higher postoperative complication rates, and reduced survival. Body-composition assessment, particularly through computed tomography–based analysis, provides clinically relevant prognostic information beyond conventional anthropometric parameters. Emerging evidence also supports the role of morphofunctional assessment, including muscle strength, physical performance, and muscle ultrasound, for identifying patients at nutritional risk and improving risk stratification. In parallel, multimodal supportive-care strategies integrating nutritional intervention, exercise, and prehabilitation have shown potential to preserve functional status and improve treatment preparedness. Malnutrition, sarcopenia, and adverse body-composition phenotypes represent important predictors of clinical outcomes in patients with HNC. The incorporation of morphofunctional assessment into routine clinical practice may facilitate earlier identification of vulnerable patients and support more individualized nutritional and rehabilitative interventions. Future research should prioritize longitudinal morphofunctional assessment, standardization of assessment methods, and the integration of personalized supportive-care strategies throughout the oncologic trajectory.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.